A Study of Lebrikizumab in Patients with Persistent Moderate to Severe Atopic Dermatitis

Update Il y a 5 ans
Reference: EUCTR2014-000049-56

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this study is to evaluate the efficacy and safety of lebrikizumab used as adjunctive therapy with topical corticosteroid (TCS) compared with TCS alone in patients with persistent moderate to severe atopic dermatitis.


Inclusion criteria

  • Atopic dermatitis